Hudson Valley Investment Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
Hudson Valley Investment Advisors's ABBV Position: Q2 2026 in Review
Hudson Valley Investment Advisors reduced its AbbVie (ABBV) stake by 0.15% in Q2 2026, selling an estimated $14.8K and leaving 45,583 shares worth $11.5M. The position accounts for 1.39% of the portfolio, ranked #17.
Hudson Valley Investment Advisors first reported a position in ABBV in Q3 2022 and has held it in 16 quarters since. The position peaked at $11.7M in Q3 2025. 2,113 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Hudson Valley Investment Advisors held 45,583 shares of AbbVie worth $11.5M as of Q2 2026.
- Hudson Valley Investment Advisors sold 69 AbbVie shares in Q2 2026, an estimated $14.8K.
- AbbVie made up 1.39% of Hudson Valley Investment Advisors's portfolio in Q2 2026, its #17 holding.
- Hudson Valley Investment Advisors first reported a position in AbbVie in Q3 2022 and has held it in 16 quarters since.
- Hudson Valley Investment Advisors's AbbVie position peaked at $11.7M in Q3 2025.
- 2,113 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Hudson Valley Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.